Lack of established risk factors hampers research: Cantox

By Shane Starling in Brussels

- Last updated on GMT

Related tags: Epidemiology, Nutrition, Clinical trial, European food safety authority

Cantox Health Science International’s Canadian-based, Food and Nutrition associate director, Kathy Musa-Velosa PhD, tells Shane Starling about how risk factors and biomarkers are being used as measures for disease reduction health claims.

She explains how a lack of established risk factors in the European Union is hampering trial design and claim submission, with learnings coming on a case-by-case basis as European Food Safety Authority opinions are issued.

“There is a lot of frustration,” ​she said. “The industry have been told their data is not good enough ... they are trying to invest in better clinical studies but there is this uncertainty about what they should be measuring...”

Related products

show more

MenaQ7® Partners Benefit From K2 Outreach

MenaQ7® Partners Benefit From K2 Outreach

NattoPharma USA, Inc. | 22-Apr-2019 | Case Study

MenaQ7® K2 as MK-7 provides health benefits for all ages. That is a fact clinically proven by NattoPharma and communicated to practitioners and consumers...

K2 for Heart Health? MenaQ7 Only Proven, Patented

K2 for Heart Health? MenaQ7 Only Proven, Patented

NattoPharma USA, Inc. | 22-Oct-2018 | Research Study

Vitamin K2 has earned media and the medical community’s attention due to a strong body of evidence showing it simultaneously supports bone and cardiovascular...

Related suppliers

Follow us

Featured Events

View more

Products

View more

Webinars